Daniel Röshammar
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
- Virology 8
- HIV Research and Treatment 8
- Co-authors
- Michael AshtonJackson MukonzoCharles F. B. NhachiCollen MasimirembwaEmmanuel ChigutsaProsper ChonziDinko RekićLars L. Gustafsson
- Journals
- Journal of Pharmacokinetics and Pharmacodynamics (4 papers)British Journal of Clinical Pharmacology (3 papers)CPT Pharmacometrics & Systems Pharmacology (2 papers)The AAPS Journal (2 papers)European Journal of Clinical Pharmacology (2 papers)
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Daniel Röshammar
22 papers receiving 548 citations
Peers
Comparison fields: 5 of 73
- Virology 149
- Infectious Diseases 264
- Pharmacology 113
- Internal Medicine 20
- Pediatrics, Perinatology and Child Health 72
Countries citing papers authored by Daniel Röshammar
This map shows the geographic impact of Daniel Röshammar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Röshammar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Röshammar more than expected).
Fields of papers citing papers by Daniel Röshammar
This network shows the impact of papers produced by Daniel Röshammar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Röshammar. The network helps show where Daniel Röshammar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daniel Röshammar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 10 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 2 | |
| 4 | 2022 | 15 | |
| 5 | 2021 | 15 | |
| 6 | 2017 | 31 | |
| 7 | 2016 | 14 | |
| 8 | 2016 | 10 | |
| 9 | 2016 | 3 | |
| 10 | 2013 | 6 | |
| 11 | 2012 | 3 | |
| 12 | 2012 | 17 | |
| 13 | 2011 | 25 | |
| 14 | 2011 | 11 | |
| 15 | 2011 | 3 | |
| 16 | 2010 | 37 | |
| 17 | 2009 | 114 | |
| 18 | 2007 | 151 | |
| 19 | 2007 | 37 | |
| 20 | 2006 | 38 |
About Daniel Röshammar
Daniel Röshammar is a scholar working on Virology, Internal Medicine, Infectious Diseases, Emergency Medicine and Statistics and Probability, having authored 22 papers that have together received 564 indexed citations. Recurring topics across this work include HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (8 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Psychedelics and Drug Studies (3 papers), Diabetes Treatment and Management (3 papers), Neurotransmitter Receptor Influence on Behavior (3 papers), Chemical synthesis and alkaloids (3 papers) and HIV-related health complications and treatments (3 papers). The work is most often cited by research in Virology (149 citations), Infectious Diseases (264 citations), Pharmacology (113 citations), Internal Medicine (20 citations) and Pediatrics, Perinatology and Child Health (72 citations). Daniel Röshammar has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Michael Ashton, Jackson Mukonzo, Charles F. B. Nhachi, Collen Masimirembwa, Emmanuel Chigutsa, Prosper Chonzi, Dinko Rekić, Lars L. Gustafsson, Eleni Aklillu and Jasper Ogwal‐Okeng. Their work appears in journals such as Journal of Pharmacokinetics and Pharmacodynamics, British Journal of Clinical Pharmacology, CPT Pharmacometrics & Systems Pharmacology, The AAPS Journal and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.